Cargando…

A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease

BACKGROUND: Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true slowing of the neurodegenerative process. A systematic review was undertaken to determine what bioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGhee, David J. M., Ritchie, Craig W., Thompson, Paul A., Wright, David E., Zajicek, John P., Counsell, Carl E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928315/ https://www.ncbi.nlm.nih.gov/pubmed/24558437 http://dx.doi.org/10.1371/journal.pone.0088854

Ejemplares similares

A systematic review of biomarkers for disease progression in Parkinson’s disease
por: McGhee, David JM, et al.
Publicado: (2013)

A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer’s disease and Parkinson’s disease
por: McGhee, David J. M., et al.
Publicado: (2016)

Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
por: McGhee, David, et al.
Publicado: (2015)

Selection of subjects for clinical trials in Alzheimer’s disease and mild cognitive impairment with machine learning analysis of MRI and CSF biomarkers
por: Escudero, Javier, et al.
Publicado: (2011)

Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
Publicado: (2014)

Systematic Review of Prevalence Studies of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Swallow, Diane M.A., et al.
Publicado: (2022)

Molecular biomarkers of Alzheimer's disease: progress and prospects
por: Lashley, Tammaryn, et al.
Publicado: (2018)

The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease
por: Ritchie, Craig W, et al.
Publicado: (2012)

Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPD
por: Hanlon, Peter, et al.
Publicado: (2023)

Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
por: Temmerman, Joke, et al.
Publicado: (2023)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Computed tomographic pulmonary angiography and pulmonary embolism: predictive value of a d-dimer assay
por: Deonarine, Patricia, et al.
Publicado: (2012)

Sphere-forming cells from peripheral cornea demonstrate the ability to repopulate the ocular surface
por: Mathan, Jeremy John, et al.
Publicado: (2016)

Systematic Analysis and Biomarker Study for Alzheimer’s Disease
por: Li, Xinzhong, et al.
Publicado: (2018)

Vaccines for mucosal immunity to combat emerging infectious diseases.
por: van Ginkel, F W, et al.
Publicado: (2000)

The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)
por: Swallow, Diane M. A., et al.
Publicado: (2023)

The Rapid Transformation of Transplantation for Corneal Endothelial Diseases: An Evolution From Penetrating to Lamellar to Cellular Transplants
por: Zhang, Jie, et al.
Publicado: (2019)

Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
por: Swarbrick, S., et al.
Publicado: (2019)

Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review
por: Gleerup, Helena Sophia, et al.
Publicado: (2019)

Abastecimiento de agua y alcantarillado : ingeniería ambiental /
por: McGhee, Terence J.
Publicado: (1999)

THE INFECTION BY PLASMODIUM LOPHURAE OF DUCK ERYTHROCYTES IN THE CHICKEN EMBRYO
por: McGhee, R. Barclay
Publicado: (1953)

Inventario cinco factores de personalidad para niños : FFPI-C /
por: McGhee, Ronnie L.
Publicado: (2019)

Máxima productividad : recupera tu vida usando Microsoft Outlook
por: McGhee, Sally, 1959-
Publicado: (2010)

Learning Biomarker Models for Progression Estimation of Alzheimer’s Disease
por: Schmidt-Richberg, Alexander, et al.
Publicado: (2016)

Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives
por: Huang, Shan, et al.
Publicado: (2022)

Disease Modelling of Cognitive Outcomes and Biomarkers in the European Prevention of Alzheimer’s Dementia Longitudinal Cohort
por: Howlett, James, et al.
Publicado: (2021)

Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer’s Disease: A Systematic Review
por: de la Fuente Garcia, Sofia, et al.
Publicado: (2020)

Coevolutionary Constraints? The Environment Alters Tripartite Interaction Traits in a Legume
por: Heath, Katy D., et al.
Publicado: (2012)

Is late-onset Alzheimer's disease really a disease of midlife?
por: Ritchie, Karen, et al.
Publicado: (2015)

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
por: Zajicek, John, et al.
Publicado: (2013)

Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy by Aspelund et al. (2011) Diabetologia 54:2525–2532
por: McGhee, Sarah, et al.
Publicado: (2012)

Improving cardiac operating room to intensive care unit handover using a standardised handover process
por: Gleicher, Yehoshua, et al.
Publicado: (2017)

Partial Differential Equations: A unified Hilbert Space Approach
por: Picard, Rainer, et al.
Publicado: (2011)

Predictors of functional dependency in Parkinson's disease
por: Macleod, Angus D., et al.
Publicado: (2016)

Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review
por: Agarwal, Mehak, et al.
Publicado: (2020)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
por: Cullen, Nicholas C., et al.
Publicado: (2020)

Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
por: Varesi, Angelica, et al.
Publicado: (2022)

Blood Analytes as Biomarkers of Mechanisms Involved in Alzheimer’s Disease Progression
por: Baldini, Andrea, et al.
Publicado: (2022)

Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios
por: Bouwman, Femke H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_55ncs5u1iegpha7qvh1sqgmhfb